Published in Mediators Inflamm on December 01, 2001
House dust (1-3)-beta-D-glucan and wheezing in infants. Allergy (2007) 1.40
Influence of dog ownership and high endotoxin on wheezing and atopy during infancy. J Allergy Clin Immunol (2006) 1.36
Regulatory T cells and the control of the allergic response. J Allergy (Cairo) (2012) 0.77
Immune responses to inhalant Mammalian allergens. Front Immunol (2014) 0.76
Functions of Exosomes and Microbial Extracellular Vesicles in Allergy and Contact and Delayed-Type Hypersensitivity. Int Arch Allergy Immunol (2016) 0.75
Interleukin-13: central mediator of allergic asthma. Science (1998) 14.05
The role of cockroach allergy and exposure to cockroach allergen in causing morbidity among inner-city children with asthma. N Engl J Med (1997) 12.21
The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today (1996) 12.12
Requirement for IL-13 independently of IL-4 in experimental asthma. Science (1998) 10.76
Prospective study of body mass index, weight change, and risk of adult-onset asthma in women. Arch Intern Med (1999) 6.21
The interleukin-12/interleukin-12-receptor system: role in normal and pathologic immune responses. Annu Rev Immunol (1998) 5.50
Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet (2001) 5.25
Family size, infection and atopy: the first decade of the "hygiene hypothesis". Thorax (2000) 5.14
Increase in asthma: a more toxic environment or a more susceptible population? Thorax (1994) 3.52
Sensitisation, asthma, and a modified Th2 response in children exposed to cat allergen: a population-based cross-sectional study. Lancet (2001) 3.06
Resting respiratory tract dendritic cells preferentially stimulate T helper cell type 2 (Th2) responses and require obligatory cytokine signals for induction of Th1 immunity. J Exp Med (1998) 2.85
Risk factors for asthma in inner city children. J Pediatr (1992) 2.72
Cytokines in asthma. Thorax (1999) 2.64
Physico-chemical properties of human reaginic antibody. IV. Presence of a unique immunoglobulin as a carrier of reaginic activity. J Immunol (1966) 2.62
Role of interleukin 10 in specific immunotherapy. J Clin Invest (1998) 2.57
Reduction of bronchial hyperreactivity during prolonged allergen avoidance. Lancet (1982) 2.55
Interleukin-10 regulation in normal subjects and patients with asthma. J Allergy Clin Immunol (1996) 2.55
Interleukin 12 inhibits antigen-induced airway hyperresponsiveness, inflammation, and Th2 cytokine expression in mice. J Exp Med (1995) 2.52
Alternaria as a major allergen for asthma in children raised in a desert environment. Am J Respir Crit Care Med (1997) 2.46
Perturbed equilibrium of myosin binding in airway smooth muscle and its implications in bronchospasm. Am J Respir Crit Care Med (1999) 2.40
Airway hyperresponsiveness in asthma: a problem of limited smooth muscle relaxation with inspiration. J Clin Invest (1995) 2.36
Elevated expression of messenger ribonucleic acid encoding IL-13 in the bronchial mucosa of atopic and nonatopic subjects with asthma. J Allergy Clin Immunol (1997) 2.28
Association of asthma with serum IgE and skin test reactivity to allergens among children living at high altitude. Tickling the dragon's breath. Am J Respir Crit Care Med (1995) 2.13
Association of being overweight with greater asthma symptoms in inner city black and Hispanic children. J Pediatr (1998) 1.99
The role of allergy in the development of asthma. Nature (1999) 1.88
Does early exposure to cat or dog protect against later allergy development? Clin Exp Allergy (1999) 1.86
Childhood antecedents of allergic sensitization in young British adults. J Allergy Clin Immunol (1997) 1.67
Requirement of CD28-CD86 costimulation for allergen-specific T cell proliferation and cytokine expression. Clin Exp Allergy (1998) 1.66
Inhaled corticosteroids increase interleukin-10 but reduce macrophage inflammatory protein-1alpha, granulocyte-macrophage colony-stimulating factor, and interferon-gamma release from alveolar macrophages in asthma. Am J Respir Crit Care Med (1998) 1.65
Interleukin-4 receptor in moderate atopic asthma. A phase I/II randomized, placebo-controlled trial. Am J Respir Crit Care Med (1999) 1.62
Interleukin-4 and interleukin-13: their similarities and discrepancies. Int Rev Immunol (1998) 1.60
Haplotype associated with low interleukin-10 production in patients with severe asthma. Lancet (1998) 1.59
Effects of Th2 cytokines on chemokine expression in the lung: IL-13 potently induces eotaxin expression by airway epithelial cells. J Immunol (1999) 1.59
Nebulized IFN-gamma inhibits the development of secondary allergic responses in mice. J Immunol (1996) 1.52
Effects of recombinant human interleukin-12 on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet (2001) 1.52
Mite, cat, and cockroach exposure, allergen sensitisation, and asthma in children: a case-control study of three schools. Thorax (1999) 1.50
Interleukin-10 inhibits antigen-induced cellular recruitment into the airways of sensitized mice. J Clin Invest (1995) 1.49
Childhood environment and adult atopy: results from the European Community Respiratory Health Survey. J Allergy Clin Immunol (1999) 1.44
Development of IgE and IgG antibodies to food and inhalant allergens in children at risk of allergic disease. Arch Dis Child (1985) 1.40
Induction and regulation of the IgE response. Nature (1999) 1.30
IL-10: a potential therapy for allergic inflammation? Immunol Today (1997) 1.27
Grass pollen immunotherapy inhibits allergen-induced infiltration of CD4+ T lymphocytes and eosinophils in the nasal mucosa and increases the number of cells expressing messenger RNA for interferon-gamma. J Allergy Clin Immunol (1996) 1.16
Reciprocal age-related patterns of allergen-specific T-cell immunity in normal vs. atopic infants. Clin Exp Allergy (1998) 1.16
Interleukin 18, a cytokine which resembles IL-1 structurally and IL-12 functionally but exerts its effect independently of both. Clin Immunol Immunopathol (1998) 1.10
Release of granulocyte-macrophage colony stimulating factor by human cultured airway smooth muscle cells: suppression by dexamethasone. Br J Pharmacol (1997) 1.03
Peripheral blood mononuclear cell proliferative responses in the first year of life in babies born to allergic parents. Clin Exp Allergy (1996) 1.02
Anti-CD86 (B7.2) treatment abolishes allergic airway hyperresponsiveness in mice. Am J Respir Crit Care Med (1999) 1.02
The effects of nebulized recombinant interferon-gamma in asthmatic airways. J Allergy Clin Immunol (1995) 1.00
Regulation of immunologic homeostasis in peripheral tissues by dendritic cells: the respiratory tract as a paradigm. J Allergy Clin Immunol (2000) 0.97
IL-9 pathway in asthma: new therapeutic targets for allergic inflammatory disorders. J Allergy Clin Immunol (1999) 0.95
Murine CTLA4-IgG treatment inhibits airway eosinophilia and hyperresponsiveness and attenuates IgE upregulation in a murine model of allergic asthma. Am J Respir Cell Mol Biol (1997) 0.94
Prevention of adult asthma by early intervention during childhood: potential value of new generation immunomodulatory drugs. Thorax (2000) 0.94
Airway epithelial cells and mediators of inflammation. Respir Med (1993) 0.92
The kinetics of change in cytokine production by CD4 T cells during conventional allergen immunotherapy. J Allergy Clin Immunol (1999) 0.91
Receptors and cytokines involved in allergic TH2 cell responses. J Allergy Clin Immunol (1999) 0.90
Alveolar macrophage-induced suppression of peripheral blood mononuclear cell responsiveness is reversed by in vitro allergen exposure in bronchial asthma. Eur Respir J (1994) 0.88
Changing concepts of allergic disease: the attempt to keep up with real changes in lifestyles. J Allergy Clin Immunol (1996) 0.87
Cord blood proliferative responses to inhaled allergens: is there a phenomenon? J Allergy Clin Immunol (2000) 0.86
Anti-IgE antibody therapy for asthma. N Engl J Med (1999) 0.78
Two cortical areas mediate multisensory integration in superior colliculus neurons. J Neurophysiol (2001) 1.68
Treatment of late-onset asthma with fluconazole. J Allergy Clin Immunol (1999) 1.67
Unifying multisensory signals across time and space. Exp Brain Res (2004) 1.61
Sensitization to dust mites as a dominant risk factor for asthma among adolescents living in central Virginia. Multiple regression analysis of a population-based study. Am J Respir Crit Care Med (1997) 1.55
Assessment of vacuum cleaners and vacuum cleaner bags recommended for allergic subjects. J Allergy Clin Immunol (1999) 1.45
Mechanisms of within- and cross-modality suppression in the superior colliculus. J Neurophysiol (1997) 1.34
The role of intervention in established allergy: avoidance of indoor allergens in the treatment of chronic allergic disease. J Allergy Clin Immunol (2000) 1.21
Visual localization ability influences cross-modal bias. J Cogn Neurosci (2003) 1.20
Metabotropic glutamate receptors switch visual response mode of lateral geniculate nucleus cells from burst to tonic. J Neurophysiol (1996) 1.18
Quantitative measurement of airborne allergens from dust mites, dogs, and cats using an ion-charging device. Clin Exp Allergy (2003) 1.16
Evaluation of different techniques for washing cats: quantitation of allergen removed from the cat and the effect on airborne Fel d 1. J Allergy Clin Immunol (1997) 1.15
Receiver operating characteristic (ROC) analysis of neurons in the cat's lateral geniculate nucleus during tonic and burst response mode. Vis Neurosci (1996) 1.11
Biological potency of German cockroach allergen extracts determined in an inner city population. Clin Exp Allergy (2007) 1.10
The influence of visual and auditory receptive field organization on multisensory integration in the superior colliculus. Exp Brain Res (2001) 1.09
The role of domestic allergens. Ciba Found Symp (1997) 1.03
The effectiveness of Allerpet/c in reducing the cat allergen Fel d 1. J Allergy Clin Immunol (1997) 0.98
Rise in asthma cases. Science (1997) 0.95
Con: the increase in asthma cannot be ascribed to cleanliness. Am J Respir Crit Care Med (2001) 0.94
Determinants of clinical allergic disease. The relevance of indoor allergens to the increase in asthma. Am J Respir Crit Care Med (2000) 0.94
Sensitization to food and inhalant allergens in relation to age and wheeze among children with atopic dermatitis. Clin Exp Allergy (2013) 0.92
Serum IgG and IgG4 antibodies to Fel d 1 among children exposed to 20 microg Fel d 1 at home: relevance of a nonallergic modified Th2 response. Int Arch Allergy Immunol (2001) 0.91
Mechanisms of tolerance induction in allergic disease: integrating current and emerging concepts. Clin Exp Allergy (2013) 0.88
Is there a dose-response relationship between exposure to indoor allergens and symptoms of asthma? J Allergy Clin Immunol (1995) 0.88
The role of indoor allergens in asthma. Allergy (1995) 0.87
Changing concepts of allergic disease: the attempt to keep up with real changes in lifestyles. J Allergy Clin Immunol (1996) 0.87
Cord blood proliferative responses to inhaled allergens: is there a phenomenon? J Allergy Clin Immunol (2000) 0.86
Chronic dermatophytosis in lamellar ichthyosis: relevance of a T-helper 2-type immune response to Trichophyton rubrum. Br J Dermatol (2001) 0.84
Cat allergy. Ann Allergy (1992) 0.83
The long-term protective effects of domestic animals in the home. Clin Exp Allergy (2011) 0.80
Asthma and indoor air: contrasts in the dose response to cat and dust-mite. Indoor Air (2005) 0.80
Dynamic splinting after extensor tendon repair in zones V to VII. J Hand Surg Br (2003) 0.79
Latency variability of responses to visual stimuli in cells of the cat's lateral geniculate nucleus. Exp Brain Res (1995) 0.78
Relevance of early or current pet ownership to the prevalence of allergic disease. Clin Exp Allergy (2002) 0.78
Infection with human rhinovirus 16 promotes enhanced IgE responsiveness in basophils of atopic asthmatics. Clin Exp Allergy (2014) 0.78
The immune response to Trichophyton tonsurans: distinct T cell cytokine profiles to a single protein among subjects with immediate and delayed hypersensitivity. J Immunol (1996) 0.77
Monitoring allergen exposure in asthma: new treatment strategies. Allergy (1995) 0.75
Microbes and man: an evolving story in asthma. Clin Exp Allergy (2009) 0.75
Increased incidence of skin infections in atopy: evidence for an antigen-specific homing defect? Clin Exp Allergy (2002) 0.75
[Washington regime after-care of flexor tendon injuries in zone 2]. Handchir Mikrochir Plast Chir (1996) 0.75
Disposal of radioactive wastes from U. S. Naval nuclear-powered ships and their support facilities. Radiol Health Data Rep (1966) 0.75
Effects of N-ethylmaleimide treatment on the action potential Na+-ionophore of cultured neuroblastoma cells. J Neurochem (1980) 0.75
ENTEROANASTOMOSIS IN INTESTINAL OBSTRUCTION. Ann Surg (1930) 0.75
ANOTHER "CURE FOR CANCER.". Cal State J Med (1915) 0.75